Skip to content
Clinical Trials – home

Rheumatologische Schwerpunktpraxis

Research site

Germany Viktoria-Luise-Platz 12, 10777 Berlin, Germany

  • Psoriatic arthropathy · Rheumatoid arthritis
  • Adult patients

About Specializations

Rheumatologische Schwerpunktpraxis in Berlin, Germany specialises in clinical trials of conditions such as Psoriatic arthropathy, Rheumatoid arthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatoid Arthritis Research

The Rheumatologische Schwerpunktpraxis in Berlin focuses on immune system diseases, especially Rheumatoid Arthritis. Ongoing trials evaluate innovative treatments to improve patient outcomes.

  • Evaluation of novel kinase inhibitor tulisokibart
  • Placebo‑controlled efficacy assessment
  • Measurement of ACR20 response at 12 weeks

These studies aim to determine whether the investigational drug can provide faster symptom relief and functional improvement for people with rheumatoid arthritis, supporting future treatment guidelines.

Psoriatic Arthritis Research

Investigators at the Berlin location are advancing therapies for Psoriatic Arthritis, a major focus within immune system diseases. The work centers on testing safety and optimal dosing of emerging agents.

  • Dose‑finding study of JNJ‑88545223
  • Comparison with placebo
  • Evaluation of clinical response and safety profile

The goal is to identify effective dosing strategies that could offer new options for patients with active psoriatic arthritis, enhancing disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Viktoria-Luise-Platz 1210777 BerlinGermany
Recruiting now
no trials
Conditions studied
2

More sites in BerlinGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Janssen Cilag International

Rheumatoid arthritis

Not recruiting

A study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.